The FDA today labeled Teleflex‘s (NYSE:TFX) recall of Arrow intra-aortic balloon cath and percutaneous insertion kits as a Class I recall. Class I recall designations, the agency’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The devices are being […]
Hospital group purchasing organizations Novation and Premier signed new contracts this week, covering patient monitoring solutions, intra-aortic balloon catheters and pumps.
Novation awarded a three-year contract to Spacelabs Healthcare, a subsidiary of OSI Systems Inc. (NSDQ:OSIS), for patient monitoring and connectivity solutions.
Teleflex Inc. (NYSE:TFX) announced that it successfully resolved all outstanding issues cited in a FDA Warning Letter regarding quality systems control issues at its subsidiary Arrow International.
The Warning Letter was sent in October 2007, just weeks after Limerick, Pa.-based Teleflex completed its acquisition of Arrow.
A former sales rep for Exactech Inc. avoided prison but landed five years’ probation and $56,000 in fines after pleading guilty to setting up a kickbacks scheme to encourage orthopedic surgeons to use the company’s hip and knee implants.
Judge Garrett Brown of the U.S. District Court for New Jersey handed down the sentence to Douglas Donofrio, the former New York-area sales director for the Gainesville, Fla.-based company. Donofrio pleaded guilty to running the scheme between 2002 and 2008.